Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.9%

13 terminated/withdrawn out of 164 trials

Success Rate

91.0%

+4.5% vs industry average

Late-Stage Pipeline

34%

56 trials in Phase 3/4

Results Transparency

14%

18 of 132 completed trials have results

Key Signals

4 recruiting18 with results9 withdrawn

Enrollment Performance

Analytics

N/A

62(49.2%)

Phase 4

52(41.3%)

Phase 2

7(5.6%)

Phase 3

4(3.2%)

Phase 1

1(0.8%)

126Total

N/A(62)

Phase 4(52)

Phase 2(7)

Phase 3(4)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (164)

Showing 20 of 164 trials

NCT07398365Recruiting

Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

Role: collaborator

NCT06719674Not ApplicableActive Not Recruiting

Diode Laser as an Adjunct to Professional Mechanical Plaque Removal

Role: collaborator

NCT04419805Not ApplicableActive Not Recruiting

Single Palatal Temporary Anchorage Device for Anterior Open Bite

Role: lead

NCT03356405Completed

Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV

Role: lead

NCT03696290Phase 4Terminated

Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis

Role: lead

NCT07194915Active Not Recruiting

Pleural Fluid Neutrophil Extracellular Traps Exacerbate Disease Severity and Risk of One-year Mortality in Pleural Infection (TORPIDS-3)

Role: collaborator

NCT04343950Not ApplicableCompleted

SMS Messaging as a Tool to Improve Cancer Screening Programs

Role: collaborator

NCT06435156Phase 2Recruiting

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

Role: lead

NCT07125365Recruiting

UK Islet Autoantibody Registry

Role: collaborator

NCT06388291Not ApplicableCompleted

Deep Brain Stimulation in Tourette Syndrome

Role: collaborator

NCT03439345Phase 4Completed

Lowering Events in Non-proliferative Retinopathy in Scotland

Role: collaborator

NCT03747627Active Not Recruiting

BPF Genetics of ILD Study

Role: lead

NCT02526004Not ApplicableCompleted

Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified

Role: collaborator

NCT06871878Not ApplicableNot Yet Recruiting

Feasibility of a Physiotherapy Programme, with Integrated TelerehabIlitation to Increase Rehabilitation Time and Improve Motor Function

Role: collaborator

NCT05582798Phase 4Completed

Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function

Role: lead

NCT04290273Not ApplicableWithdrawn

Characterisation of the Time-course Response of UV-induced Erythema

Role: lead

NCT05408169Not ApplicableCompleted

Increasing Uptake of Bowel Screening

Role: collaborator

NCT04817332Phase 3Completed

STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19

Role: lead

NCT04159545Completed

Future Destinations: Journeys Towards Citizenship

Role: lead

NCT00995475Phase 4Completed

A Proof of Concept Study to Evaluate the Dose Response for the Systemic Benefit Risk Ratio of Inhaled Fluticasone Propionate in Chronic Obstructive Pulmonary Disease

Role: lead